Jump to content

Biosplice Therapeutics

From Wikipedia, the free encyclopedia
(Redirected from Samumed)
Biosplice Therapeutics
Company typePrivately held company
IndustryRegenerative medicine
Founded2008; 16 years ago (2008) in San Diego, USA
FounderOsman Kibar
Faterenamed from Samumed
Headquarters
San Diego, USA
Websitewww.biosplice.com

Biosplice Therapeutics, Inc. (formerly Samumed, LLC) is a private biopharmaceutical company based in San Diego, California.[1] It was founded in 2008 by Osman Kibar.[2]

Samumed's products in development target novel components of the Wnt signaling pathway.[3][4][5] The company focuses on potential treatments for several diseases; its osteoarthritis program is its most advanced.[4][6]

References

[edit]
  1. ^ "Small-molecule therapeutics using Biosplice Therapeutics". Business Outreach. 2023-08-16. Retrieved 2024-07-06.
  2. ^ "Forbes Profile: Osman Kibar", "Forbes"
  3. ^ Herper, Matthew."Cure Baldness? Heal Arthritis? Erase Wrinkles? An Unknown Billionaire's Quest To Reverse Aging", "Forbes", May 10, 2016
  4. ^ a b Ramsey, Lydia. "A $12 billion startup you've probably never heard wants to cure baldness and smooth out your wrinkles", "Business Insider", April 2, 2017
  5. ^ Lee, Yoolim. "Eternal Youth Is the Next Big Bet for Singapore Venture Capitalist", "Bloomberg", February 9, 2017
  6. ^ Jackson, Mandy. "ACR Notebook: Lilly's Baricitinib Differentiates On Pain, Ironwood's Duzallo Progress, Corbus Nears Phase III", "Informa Scrip", November 8, 2017"